DHCT(SH:600844)2024-10-30 07:35Financial Performance - The company's operating revenue for Q3 2024 was ¥187,288,853.09, representing a year-on-year increase of 24.25%[2] - The net profit attributable to shareholders was -¥86,748,683.08, with a year-to-date net profit of -¥198,573,656.37[2] - The basic and diluted earnings per share for the quarter were both -¥0.0853, with a year-to-date figure of -¥0.1953[3] - Total revenue for the first three quarters of 2024 was CNY 586,854,229.49, a decrease of 9.66% compared to CNY 649,641,860.35 in the same period of 2023[14] - The net loss attributable to shareholders for the third quarter of 2024 was CNY 198,573,656.37, compared to a loss of CNY 175,903,914.13 in the same quarter of 2023[16] - The total comprehensive income for the third quarter of 2024 was -255,775,175.86 CNY, compared to -227,808,698.27 CNY in the same period of 2023, reflecting a decline[17] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,348,078,149.33, a decrease of 7.97% compared to the end of the previous year[3] - The equity attributable to shareholders decreased by 37.15% to ¥339,516,183.48 compared to the previous year[3] - Current liabilities increased to CNY 747,478,489.30 in Q3 2024 from CNY 627,013,472.83 in Q3 2023, representing an increase of about 19.2%[14] - The company's total non-current liabilities amounted to CNY 77,040,228.68 in Q3 2024, up from CNY 58,484,607.77 in Q3 2023, reflecting an increase of approximately 31.6%[14] - The total equity attributable to shareholders decreased to CNY 339,516,183.48 in Q3 2024 from CNY 540,194,036.02 in Q3 2023, a decline of approximately 37.1%[14] Cash Flow - The net cash flow from operating activities for the year-to-date period was -¥48,759,956.07, showing an improvement from -¥90,701,059.09 in the previous period[6] - The net cash flow from operating activities for the first three quarters of 2024 was -48,759,956.07 CNY, an improvement from -90,701,059.09 CNY in the previous year[19] - The net cash flow from investing activities for the first three quarters of 2024 was -9,196,638.16 CNY, compared to -1,826,257.93 CNY in the same period of 2023, showing a significant increase in cash outflow[19] - The net cash flow from financing activities for the first three quarters of 2024 was 56,552,306.17 CNY, slightly down from 65,689,255.66 CNY in 2023[19] - The cash outflow from operating activities in the third quarter of 2024 was 768,394,334.90 CNY, compared to 883,069,345.25 CNY in the same quarter of 2023, indicating a reduction in cash outflow[19] Operational Challenges - The company continues to face operational losses, impacting its equity and overall financial health[6] - The company is currently facing operational losses due to low market prices for its main products, despite normal production operations at its subsidiary Tongliao Jinmei Chemical Co., Ltd.[10] - A lawsuit has been filed against the company for alleged false statements during a 2015 private placement, with a claim for damages amounting to CNY 132,754,299[10] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 52,802[7] - The company has not reported any significant changes in its major shareholders or their participation in margin trading activities[9] Asset Composition - As of September 30, 2024, the company's current assets totaled CNY 136,496,613.18, a slight increase from CNY 135,979,817.36 at the end of 2023, indicating a growth of approximately 0.38%[12] - The company's cash and cash equivalents decreased to CNY 21,351,271.97 from CNY 25,123,643.42, representing a decline of about 15.5%[12] - Inventory levels rose significantly to CNY 82,634,114.48, up from CNY 62,866,353.17, marking an increase of approximately 31.6%[12] - The company reported a significant decrease in accounts receivable, which fell to CNY 1,031,615.78 from CNY 23,010,715.38, a reduction of about 95.5%[12] - The company's long-term equity investments decreased to CNY 6,242,414.20 from CNY 7,236,413.76, reflecting a decline of approximately 13.8%[12] - The company's other equity instrument investments also saw a decrease, falling to CNY 25,304,592.64 from CNY 31,027,870.62, a drop of about 18.4%[12] Expenses - Operating costs for the third quarter of 2024 were CNY 830,193,837.29, down from CNY 883,182,200.68 in the previous year, reflecting a reduction of approximately 5.97%[16] - Research and development expenses decreased to CNY 19,210,979.22 in 2024 from CNY 25,322,704.06 in 2023, indicating a reduction of about 24.2%[16]